Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo

BACKGROUND: Multidrug resistance (MDR) is a complex phenomenon that frequently leads to chemotherapy failure during cancer treatment. The overexpression of ATP-binding cassette (ABC) transporters represents the major mechanism contributing to MDR. To date, no effective MDR modulator has been applied...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuchen, Li, Cheukfai, Xia, Chenglai, Wah To, Keneth Kin, Guo, Zhixing, Ren, Chongyang, Wen, Lingzhu, Wang, Fang, Fu, Liwu, Liao, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472360/
https://www.ncbi.nlm.nih.gov/pubmed/36104708
http://dx.doi.org/10.1186/s12964-022-00955-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472360/
https://www.ncbi.nlm.nih.gov/pubmed/36104708
http://dx.doi.org/10.1186/s12964-022-00955-8

Ejemplares similares